Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 5
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease.
Bouba Y, Armenia D, Forbici F, Bertoli A, Borghi V, Gagliardini R, Vergori A, Cicalini S, Mazzotta V, Malagnino V, Lichtner M, Latini A, Mussini C, Andreoni M, Antinori A, Perno CF, Ceccherini-Silberstein F, Santoro MM. Bouba Y, et al. J Antimicrob Chemother. 2021 Nov 12;76(12):3272-3279. doi: 10.1093/jac/dkab322. J Antimicrob Chemother. 2021. PMID: 34529797
HIV MDR is still a relevant issue despite its dramatic drop over the years.
Armenia D, Di Carlo D, Flandre P, Bouba Y, Borghi V, Forbici F, Bertoli A, Gori C, Fabeni L, Gennari W, Pinnetti C, Mondi A, Cicalini S, Gagliardini R, Vergori A, Bellagamba R, Malagnino V, Montella F, Colafigli M, Latini A, Marocco R, Licthner M, Andreoni M, Mussini C, Ceccherini-Silberstein F, Antinori A, Perno CF, Santoro MM. Armenia D, et al. Among authors: bouba y. J Antimicrob Chemother. 2020 May 1;75(5):1301-1310. doi: 10.1093/jac/dkz554. J Antimicrob Chemother. 2020. PMID: 31976521
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice.
Armenia D, Bouba Y, Gagliardini R, Fabeni L, Borghi V, Berno G, Vergori A, Cicalini S, Mussini C, Antinori A, Ceccherini-Silberstein F, Perno CF, Santoro MM. Armenia D, et al. Among authors: bouba y. HIV Med. 2021 Jul;22(6):519-525. doi: 10.1111/hiv.13062. Epub 2021 Jan 21. HIV Med. 2021. PMID: 33480094
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings.
Armenia D, Bouba Y, Gagliardini R, Gori C, Bertoli A, Borghi V, Gennari W, Micheli V, Callegaro AP, Gazzola L, Bruzzone B, Giannetti A, Mazzotta V, Vergori A, Mastrorosa I, Colafigli M, Lichtner M, di Biagio A, Maggiolo F, Rizzardini G, d'Arminio Monforte A, Andreoni M, Mussini C, Antinori A, Ceccherini-Silberstein F, Perno CF, Santoro MM; Italian INI-Surveillance Group. Armenia D, et al. Among authors: bouba y. J Clin Virol. 2020 Sep;130:104534. doi: 10.1016/j.jcv.2020.104534. Epub 2020 Jul 11. J Clin Virol. 2020. PMID: 32769022
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches.
Vergni D, Santoni D, Bouba Y, Lemme S, Fabeni L, Carioti L, Bertoli A, Gennari W, Forbici F, Perno CF, Gagliardini R, Ceccherini-Silberstein F, Santoro MM; HIV drug-resistance group. Vergni D, et al. Among authors: bouba y. Infect Genet Evol. 2022 Jul;101:105294. doi: 10.1016/j.meegid.2022.105294. Epub 2022 May 2. Infect Genet Evol. 2022. PMID: 35513162 Free article.
Thrombocytopenia according to antiretroviral drug combinations, viremia and CD4 lymphocytes among HIV-infected patients in Cameroon: a snapshot from the City of Yaoundé.
Nka AD, Sosso SM, Fokam J, Bouba Y, Teto G, Simo Rachel R, Tiga A, Yimga J, Nukenine EN, Nanfack AJ, Takou D, Aroga Z, Colizzi V, Ndjolo A. Nka AD, et al. Among authors: bouba y. BMC Res Notes. 2019 Sep 26;12(1):632. doi: 10.1186/s13104-019-4664-7. BMC Res Notes. 2019. PMID: 31554515 Free PMC article.
13 results